annb0t
Top 20
Immutep Limited
Fast Track designation has been granted by the US FDA for efti in combination with pembrolizumab in 1st line non-small cell lung cancer Based on the encouraging Phase II clinical data for PD-L1 all-comers presented at ASCO 2022 Marks the second Fast Track designation issued by the FDA for eftilagimod alpha, offering the potential for expedited development and review
SYDNEY, AUSTRALIA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or ...
>>> Read more: Immutep Receives FDA Fast Track Designation for LAG-3 Therapeutic Eftilagimod Alpha for First Line Non-Small Cell Lung Cancer
Fast Track designation has been granted by the US FDA for efti in combination with pembrolizumab in 1st line non-small cell lung cancer Based on the encouraging Phase II clinical data for PD-L1 all-comers presented at ASCO 2022 Marks the second Fast Track designation issued by the FDA for eftilagimod alpha, offering the potential for expedited development and review
SYDNEY, AUSTRALIA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or ...
>>> Read more: Immutep Receives FDA Fast Track Designation for LAG-3 Therapeutic Eftilagimod Alpha for First Line Non-Small Cell Lung Cancer
